← Home / IONIS PHARMACEUTICALS, INC. (IONS)
Stock Analysis
IONIS PHARMACEUTICALS, INC. (IONS)
IONS
IONS · Market data
58.25 -9.37%
52W Range Position
38%
LOWMIDHIGH
Trend
Vulnerable
Momentum
Neutral
Updated: 2026-07-12 19:50 UTC
WOI Investment Thesis
Vulnerable
Watch confirmation and invalidation levels before acting.
⚖️
Fundamentals
Moderate / Negative
Price Structure
Vulnerable
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
Hold Above
Structure remains valid above support.
Break Above
Confirmation improves above resistance.
71.51
🎯
Next Objective
Pattern-derived target if setup continues.
×
Thesis Break
Scenario weakens below invalidation.
Below —
What's Driving IONS?
📈 Technical recovery is improving
Momentum is Neutral. Watch 71.51 for confirmation and for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
26.5
Price Chart
IONS · WOI overlay chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-09
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$10.7B
Company size
EV
$12.7B
Debt-adjusted value
P/E
-32.6
Not meaningful
P/S
10.1
Premium
P/B
21.7
Very high
EV/Sales
12.0
Premium
EV/EBIT
-36.1
Not meaningful
P/FCF
-32.4
Not meaningful
FCF Yield
-3.09%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
Revenue Growth
Moderate
Profitability
Negative
Cash Flow
Pressured
Balance Sheet
Pressured
💵 Revenue
246.09M
≈ Moderate
📈 Net Income
-92.53M
↘ Negative
🧮 EPS (Basic)
-0.56
↘ Negative
IONIS PHARMACEUTICALS, INC.